Quince Therapeutics, Inc.
SEC Filing List
QNCX CIK: 0001662774
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 08/14/2026 | |||
| SCHEDULE 13G | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 08/14/2026 | |||
| SCHEDULE 13G/A | Toppan Merrill/FA | 08/14/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/14/2026 | |
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/14/2026 | |||
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/14/2026 | |
| S-3/A | Amendment to Registration statement for ... | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/05/2026 | |
| SCHEDULE 13G | 08/04/2026 | ||||
| PRE 14A | Preliminary proxy statement not related ... | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/31/2026 | |
| 8-K | Current report filing | Quince Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/31/2026 | |
| No record found. | |||||
| Load More | |||||
